Sanofi (SNY)
A+
Pipeline Grade
Drug Pipeline (3 Assets)
| Drug | Phase | Indications |
|---|---|---|
|
FEXINIDAZOLE
FEXINIDAZOLE |
APPROVED | Acid Maltase Deficiency Disease, Acne, Acne Vulgaris, Acquired Thrombotic Thrombocytopenic Purpura, Actinic Keratoses, Acute Coronary Syndrome, Acute Coronary Syndromes, Acute Illness, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukaemia, Acute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia, Acute Myelogenous Leukemia (AML), Acute Myeloid Leukemia, Acute Myeloid Leukemia NOS, Acute Myocardial Infarction, Acute ST-Segment Elevation, Adenocarcinoma of the Prostate, Advanced Breast Cancer, Advanced Colorectal Carcinoma, Advanced Epithelial Ovarian Cancer, Advanced Squamous Cell Carcinoma, Adverse Effects, Aging, AL Amyloidosis, Allergic Rhinitis, Allogenic Stem Cell Transplantation, Alport Syndrome, Alzheimer Disease, Alzheimer's Disease, Ampullary Carcinoma, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (Healthy Volunteers), Anaplastic Astrocytoma (AA), Anaplastic Oligodendroglioma (AO), Ankylosing Spondylitis, Anticoagulants, Anxiety Disorders, Arsenic--Toxicology, A |
|
DOXERCALCIFEROL
HECTOROL |
NDA | 4H Syndrome, Abdominal Adhesions, Abdominal Neoplasms, Acid Maltase Deficiency (AMD), Acid Maltase Deficiency Disease, Acid Sphingomyelinase Deficiency, Acne, Acne Vulgaris, Actinic Keratoses, Acute Coronary Syndrome, Acute Coronary Syndromes, Acute Disseminated Encephalomyelitis, Acute Exacerbation of Chronic Bronchitis (AECB), Acute Illness, Acute Leukemia, Acute Low Back Pain, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloblastic Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukaemia, Acute Myeloid Leukemia, Acute Myocardial Infarction, Acute Promyelocytic Leukemia, Acute ST-Segment Elevation, Adenocarcinoma of the Prostate, ADLD, Adrenoleukodystrophy, Adrenomyeloneuropathy, Adult Hospitalized, Advanced Breast Cancer, Advanced Endometrial Adenocarcinoma, Stage III A, B, C, Advanced Epithelial Ovarian Cancer, Advanced Neoplastic Disease, Advanced Non-Small Cell Lung Carcinoma, Advanced Solid Tumor, Advanced Solid Tumors, Advanced Solid, Malignant Tumors, Age-Related Maculopathi |
|
TAMSULOSIN HYDROCHLORIDE
FLOMAX |
NDA | — |
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-08-08 | Phase3 Readout | — |
| 2026-09-30 | Phase1 Readout | — |
| 2026-11-01 | Phase2 Readout | — |
| 2026-11-05 | Phase3 Readout | — |
| 2026-11-30 | Phase2 Readout | — |
| 2026-12-17 | Phase2 Readout | — |
| 2027-04-01 | Phase3 Readout | — |
| 2027-04-04 | Phase1 Readout | — |
| 2027-04-28 | Phase2 Readout | — |
| 2027-05-17 | Phase3 Readout | — |
| 2027-05-17 | Phase2 Readout | — |
| 2027-05-18 | Phase2 Readout | — |
| 2027-06-02 | Phase3 Readout | — |
| 2027-06-07 | Phase3 Readout | — |
Active Clinical Trials (50)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT04848779 | A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of A... | OTHER | Active Not Recruiting | 16 |
| NCT07615166 | Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy... | OTHER | Active Not Recruiting | 124 |
| NCT01793103 | Brigham and Women's Rheumatoid Arthritis Sequential Study | OTHER | Active Not Recruiting | 1,598 |
| NCT03694561 | Developing a Management Approach for Patients With "Late-Onset" Pompe Disease | OTHER | Active Not Recruiting | 20 |
| NCT05097287 | Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontro... | PHASE4 | Active Not Recruiting | 1,339 |
| NCT06776419 | the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY Disease | OTHER | Recruiting | 54 |
| NCT00196742 | Fabry Disease Registry & Pregnancy Sub-registry | OTHER | Recruiting | 9,000 |
| NCT06824779 | Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Resp... | PHASE4 | Active Not Recruiting | 30 |
| NCT06039241 | Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis | OTHER | Recruiting | 900 |
| NCT06137261 | Screening Adults With Obesity to Reduce Heart Failure Events | OTHER | Active Not Recruiting | 420 |
| NCT06671587 | iGlarLixi CGM Study in Chinese T2D Individuals After OADs | PHASE4 | Recruiting | 678 |
| NCT03428646 | Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD) | OTHER | Active Not Recruiting | 858 |
| NCT06968975 | Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP... | OTHER | Recruiting | 200 |
| NCT06415175 | Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain | OTHER | Active Not Recruiting | 143 |
| NCT06145373 | A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Pr... | PHASE4 | Recruiting | 20 |
| NCT04743609 | RSV Burden in Outpatient and Hospital Settings | OTHER | Recruiting | 1,900 |
| NCT03992417 | Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD) | OTHER | Active Not Recruiting | 955 |
| NCT06226987 | Molecular Imaging in Fabry Disease of the Heart | OTHER | Recruiting | 12 |
| NCT07316114 | A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spont... | OTHER | Recruiting | 400 |
| NCT05053607 | Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab | OTHER | Recruiting | 50 |
| NCT04113330 | Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before... | OTHER | Active Not Recruiting | 918 |
| NCT06169527 | A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Du... | OTHER | Active Not Recruiting | 303 |
| NCT06052800 | Agalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in Taiwan | OTHER | Active Not Recruiting | 78 |
| NCT05757713 | Teplizumab in Pediatric Stage 2 Type 1 Diabetes | PHASE4 | Active Not Recruiting | 20 |
| NCT05991323 | Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study | OTHER | Active Not Recruiting | 100 |
| NCT06666413 | China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD | PHASE4 | Recruiting | 13 |
| NCT06513247 | Screening Program for Type 1 Diabetes in a High-Risk Population | OTHER | Recruiting | 1,300 |
| NCT06941870 | Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy | PHASE4 | Recruiting | 35 |
| NCT04486638 | Dengvaxia US Pregnancy Registry | OTHER | Recruiting | 500 |
| NCT06258057 | Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Preg... | OTHER | Active Not Recruiting | 365,000 |
| NCT06290128 | A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (... | PHASE3 | Recruiting | 140 |
| NCT06824181 | Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjug... | PHASE3 | Active Not Recruiting | 580 |
| NCT03754790 | Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodi... | PHASE3 | Active Not Recruiting | 281 |
| NCT07285460 | A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Year... | PHASE3 | Recruiting | 85 |
| NCT04936685 | Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5... | PHASE3 | Active Not Recruiting | 209 |
| NCT07007962 | Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed ... | PHASE3 | Recruiting | 60 |
| NCT07103148 | A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population | PHASE3 | Recruiting | 2,440 |
| NCT06687967 | A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Place... | PHASE3 | Active Not Recruiting | 142 |
| NCT06975865 | The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease | PHASE3 | Recruiting | 192 |
| NCT07348692 | Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age | PHASE3 | Recruiting | 2,195 |
| NCT06293053 | A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With... | PHASE3 | Recruiting | 18 |
| NCT05263206 | Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown O... | PHASE3 | Recruiting | 284 |
| NCT05558319 | NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide | PHASE3 | Recruiting | 480 |
| NCT06081894 | Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM | PHASE3 | Active Not Recruiting | 500 |
| NCT05280548 | A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participant... | PHASE3 | Active Not Recruiting | 104 |
| NCT04910776 | Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa | PHASE3 | Active Not Recruiting | 17 |
| NCT07412470 | A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantati... | PHASE3 | Recruiting | 526 |
| NCT06914908 | Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Poly... | PHASE2 | Enrolling By Invitation | 71 |
| NCT01736592 | Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration | PHASE2 | Active Not Recruiting | 27 |
| NCT04942210 | Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA | PHASE2 | Active Not Recruiting | 568 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.